Zura Bio (ZURA) Retained Earnings (2021 - 2026)
Zura Bio's (ZURA) quarterly Retained Earnings came in at -$248.8 million in Q1 2026, down 43.52% year-on-year from -$440.4 million in Q1 2025, and down 176.29% quarter-over-quarter from $326.1 million in Q4 2025.
Zura Bio (ZURA) Retained Earnings (2021 - 2026) Analysis & Trends
Zura Bio's Retained Earnings history runs 6 years deep, the most recent figure standing at -$248.8 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 43.52% year-over-year to -$248.8 million in Q1 2026; TTM through Mar 2026 was -$248.8 million, a 43.52% decrease from a year earlier, with the FY2025 full-year figure at $326.1 million, up 309.16% from the prior year.
- Retained Earnings eased to -$248.8 million in Q1 2026 per ZURA's latest filing, from $326.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $326.1 million in Q4 2025 and bottomed at -$248.8 million in Q1 2026.
- The 5-year median for Retained Earnings is -$41.9 million (2023), against an average of -$18.6 million.
- Biggest YoY gain for Retained Earnings was 2326.23% in 2023; the steepest drop was 1161.01% in 2023.
- Year by year, Retained Earnings stood at -$32.1 million in 2022, then plunged by 222.87% to -$103.5 million in 2023, then tumbled by 50.63% to -$155.9 million in 2024, then soared by 309.16% to $326.1 million in 2025, then tumbled by 176.29% to -$248.8 million in 2026.
- Per Business Quant, the three latest ZURA Retained Earnings figures stand at -$248.8 million (Q1 2026), $326.1 million (Q4 2025), and -$207.4 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Zura Bio | 593.66 Mn | 593.66 Mn | - | -248.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -248.77 Mn |
| Dec 31, 2025 | 326.08 Mn |
| Sep 30, 2025 | -207.37 Mn |
| Jun 30, 2025 | -189.30 Mn |
| Mar 31, 2025 | -173.34 Mn |
| Dec 31, 2024 | -155.90 Mn |
| Sep 30, 2024 | 295.31 Mn |
| Jun 30, 2024 | 278.09 Mn |
| Mar 31, 2024 | -111.24 Mn |
| Dec 31, 2023 | -103.50 Mn |
| Sep 30, 2023 | 158.23 Mn |
| Jun 30, 2023 | -86.75 Mn |
| Mar 31, 2023 | -41.90 Mn |
| Dec 31, 2022 | -32.06 Mn |
| Sep 30, 2022 | -7.11 Mn |
| Jun 30, 2022 | -6.88 Mn |
| Mar 31, 2022 | -9.03 Mn |
| Dec 31, 2021 | -9.18 Mn |